BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PYVOBJECT//NONSGML Version 1//EN
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:20260521T052541Z - 75076@eupp247
DTSTART;TZID=Europe/Berlin:20210721T150000
DTEND;TZID=Europe/Berlin:20210721T160000
CREATED:20260521T052541Z
DESCRIPTION:<a href="https://academy.ant-neuro.com/event/precision-neuromod
 ulation-in-psychiatry-neurotechnology-in-clinical-practice-20/register">Pr
 ecision neuromodulation in psychiatry: Neurotechnology in clinical practic
 e</a>\nThis webinar has ended. You can watch the recorded session here. We
 lcome to ANT Neuro Educational Webinar Series! Forms of neuromodulation in
 cluding repetitive transcranial magnetic stimulation (rTMS) are increasing
 ly being used as treatment tools in clinical practice in psychiatry\, espe
 cially in the management of patients with depression. The use of rTMS in t
 he treatment of depression is now well established by a large series of ra
 ndomised controlled trials that have demonstrated meaningful clinical effe
 cts. However\, in this webinar we will discuss how the overall efficacy of
  rTMS can be improved by increasing the precision of application\, especia
 lly through the personalisation of the method of treatment targeting and a
 lso potentially through the use of tools to personalise the frequency of s
 timulation. The scientific presentation will be followed by a virtual prod
 uct demonstration and a Q&A session. Prof. Paul Fitzgerald is Professor of
  Psychiatry at Monash University and Director of the Epworth Centre for In
 novation in Mental Health based at Epworth Camberwell. He is a qualified p
 sychiatrist\, with a Masters of Psychological Medicine and research PhD. H
 is main clinical and academic interest is in the development\, evaluation 
 and clinical translation of new therapies for mental health conditions. Hi
 s research program has been mainly focused on various forms of brain stimu
 lation including TMS\, tACS\, magnetic seizure therapy and deep brain stim
 ulation. Prof. Fitzgerald cofounded TMS Clinics Australia and he led an ap
 plication to the Medicare Services Advisory Committee that has resulted in
  a recommendation that TMS treatment for depression be funded through Medi
 care in Australia. He is also a cofounder of Resonance Therapeutics\, a co
 mpany dedicated to developing a highly novel new treatment approach for pa
 tients with depression and other conditions. We look [...]
DTSTAMP:20260521T052541Z
LOCATION:Online
SUMMARY:Precision neuromodulation in psychiatry: Neurotechnology in clinica
 l practice
X-ALT-DESC;FMTTYPE=text/html:<a href="https://academy.ant-neuro.com/event/p
 recision-neuromodulation-in-psychiatry-neurotechnology-in-clinical-practic
 e-20/register">Precision neuromodulation in psychiatry: Neurotechnology in
  clinical practice</a>\nThis webinar has ended. You can watch the recorded
  session here. Welcome to ANT Neuro Educational Webinar Series! Forms of n
 euromodulation including repetitive transcranial magnetic stimulation (rTM
 S) are increasingly being used as treatment tools in clinical practice in 
 psychiatry\, especially in the management of patients with depression. The
  use of rTMS in the treatment of depression is now well established by a l
 arge series of randomised controlled trials that have demonstrated meaning
 ful clinical effects. However\, in this webinar we will discuss how the ov
 erall efficacy of rTMS can be improved by increasing the precision of appl
 ication\, especially through the personalisation of the method of treatmen
 t targeting and also potentially through the use of tools to personalise t
 he frequency of stimulation. The scientific presentation will be followed 
 by a virtual product demonstration and a Q&A session. Prof. Paul Fitzgeral
 d is Professor of Psychiatry at Monash University and Director of the Epwo
 rth Centre for Innovation in Mental Health based at Epworth Camberwell. He
  is a qualified psychiatrist\, with a Masters of Psychological Medicine an
 d research PhD. His main clinical and academic interest is in the developm
 ent\, evaluation and clinical translation of new therapies for mental heal
 th conditions. His research program has been mainly focused on various for
 ms of brain stimulation including TMS\, tACS\, magnetic seizure therapy an
 d deep brain stimulation. Prof. Fitzgerald cofounded TMS Clinics Australia
  and he led an application to the Medicare Services Advisory Committee tha
 t has resulted in a recommendation that TMS treatment for depression be fu
 nded through Medicare in Australia. He is also a cofounder of Resonance Th
 erapeutics\, a company dedicated to developing a highly novel new treatmen
 t approach for patients with depression and other conditions. We look [...
 ]
END:VEVENT
END:VCALENDAR